Significant Ownership of Dauntless Investment Group, LLC

Signature - Title
/s/Matthew Okkerse - CFO
Location
Etna, NH
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Dauntless Investment Group, LLC.

Notify me when Dauntless Investment Group, LLC files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Dauntless Investment Group, LLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FEMY FEMASYS INC Common 9.9% $1.55M $1.05M 4.4M +207% Dauntless Investment Group, LLC Sep 30, 2025
KZIA KAZIA THERAPEUTICS LTD American Depository Shares 9.9% 177K +52.7% Dauntless Investment Group, LLC Sep 30, 2025
AEON AEON Biopharma, Inc. Common 9.7% $44.4K 108K Dauntless Investment Group, LLC Feb 26, 2025
OKYO OKYO Pharma Ltd Common 6.3% $4.88M -$632K 2.42M -11.5% Dauntless Investment Group, LLC Sep 30, 2025

Schedules 13D/G Reported by Dauntless Investment Group, LLC:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.